Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — FY2017 Earnings Presentation

15 slides from Novonesis A/s Class B's earnings presentation, Feb 7, 2018

  1. Slide 1: Novozymes Conference Call 12M 2017

    Novozymes Conference Call 12M 2017 February 7, 2018

  2. Slide 2: Good momentum

    Good momentum Solid progress on strategic priorities • Increased focus on high-growth opportunities and markets • More impactful innovation • Stronger connections between research, marketing and sales across industries and geographies Accelerating growth • Divisional structure works. More focused or

  3. Slide 3: Highlights

    Highlights Solid 2017 performance • Organic sales growth +4% (Q4: +4%) 2017 organic sales growth by segment • 4 out of 5 segments with organic growth ‒ diversity gives robustness: 11% • Household Care +1% (Q4: -3%) 9% • Food & Beverages +9% (Q4: +9%) • Bioenergy +11% (Q4: +14%) 2% 1% • Agriculture &

  4. Slide 4: Organic sales growth by geography

    Organic sales growth by geography +2% +4% Q4 y/y 12M y/y +3% +6% +12% Q4 y/y 36% +5% Q4 y/y 12M y/y of sales 12M y/y 34% 20% of sales of sales -11% -1% Q4 y/y 12M y/y 10% +3% 12M y/y 35% Emerging markets +5% of sales 12M y/y 65% Developed markets -1% +7% Q4 y/y Q4 y/y 4

  5. Slide 5: Household Care

    Household Care 32% of sales Modest sales growth in 2017. Q4 declined as expected Full-year organic sales growth • Organic growth y/y: 2017 +1%. Q4 -3% 9% • North America and Europe up for the year • Europe benefits from good dishwash enzyme sales growth 4% • Enzyme volume reductions by some large gl

  6. Slide 6: Introducing our freshness & hygiene platform

    Introducing our freshness & hygiene platform Current consumer challenges in laundry Trends increasing the need for freshness and hygiene Consumers turning to liquid detergents Yellow armpits, grime on Sweat and odor in Malodor issues in cuffs and collars sportswear washing machines Growth in use of

  7. Slide 7: Food & Beverages

    Food & Beverages 28% of sales Strong 2017 performance supported by continued good Full-year organic sales growth momentum in Q4 9% • Organic growth y/y: 2017 +9%. Q4 +9% • Solid growth across most platforms and regions; nutrition performed well with 5% increased uptake of innovation. Starch performe

  8. Slide 8: Bioenergy

    Bioenergy 18% of sales Good growth in enzymes for conventional biofuels Full-year organic sales growth 19% • Organic growth y/y: 12M +11%. Q4 +14% • US ethanol production estimated to be up 2-3% in 2017 and Q4. US ethanol 12% 11% inventories remain elevated • Growth in conventional biofuels driven a

  9. Slide 9: Agriculture & Feed

    Agriculture & Feed 15% of sales 2017 impacted by weak farm economics Full-year organic sales growth • Organic growth y/y: 12M -3%. Q4 -7% • Pick-up in Q4 demand slow, as farmers expect continued tough conditions. 19% • Feed enzyme sales soft due to weak end-market demand • Animal health continues go

  10. Slide 10: Priority innovation platforms

    Priority innovation platforms Arrows denote progress to next phase over the past 12 months 10

  11. Slide 11: Introducing "Solutions for water" as a new platform

    Introducing “Solutions for water” as a new platform • The world treats an estimated 200 billion m3 of wastewater on an annual basis • Solving the world’s water problems is a monumental challenge for society • Sustainable Development Goal #6: Clean Water and Sanitation • HelloScience established as a

  12. Slide 12: 2017 performance; 2018 outlook

    2017 performance; 2018 outlook Solid performance • 4 out of 5 segments growing Key financials Realized Outlook (DKKm) 2017 2018 • Agriculture & Feed weak in Q4 Organic sales • Emerging-market investments increasing to support growth 4% 4-6% growth • EBIT margin solid at 27.9%. ~29% excluding one-tim

  13. Slide 13: Forward-looking statements

    Forward-looking statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "bel

  14. Slide 14: Summary

    Summary Good momentum Accelerating growth Innovation is key. Faster commercialization Capital Market Days 2018 Save the date: September 17-18, Raleigh, NC 14

  15. Slide 15: Our business is about turning amazing science into sustainable biological answers

    Our business is about turning amazing science into sustainable biological answers in a growing world 6,500 2nd 48% 76 million More than 6,500 active and In 2017, Science Magazine Market leader in industrial In 2017, our customers pending patents ranked Novozymes the enzymes with an estimated avoided

Novozymes — FY2017 Earnings Presentation on 6ix